{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:09:36Z","timestamp":1793606976378,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Community's","award":["241745"],"award-info":[{"award-number":["241745"]}]},{"name":"European Community's","award":["H2020-PHC-643381"],"award-info":[{"award-number":["H2020-PHC-643381"]}]},{"name":"Agence National de Recherche","award":["ANR-05-EMPB-002-01"],"award-info":[{"award-number":["ANR-05-EMPB-002-01"]}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale FRM","doi-asserted-by":"crossref","award":["DEQ20130326471"],"award-info":[{"award-number":["DEQ20130326471"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.vaccine.2015.03.083","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T16:27:08Z","timestamp":1428769628000},"page":"2710-2718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system"],"prefix":"10.1016","volume":"33","author":[{"given":"Daria","family":"Bottai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa","family":"Frigui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Zelmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Andreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marien I.","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Bancroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscille","family":"Brodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Brosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6.","key":"10.1016\/j.vaccine.2015.03.083_bib0215","doi-asserted-by":"crossref","first-page":"a018523","DOI":"10.1101\/cshperspect.a018523","article-title":"Novel vaccination strategies against tuberculosis","volume":"4","author":"Andersen","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0220","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/1469-0691.12460","article-title":"Critical research concepts in tuberculosis vaccine development","volume":"20","author":"Delogu","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0225","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nm859","article-title":"Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis","volume":"9","author":"Pym","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0230","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1128\/jb.178.5.1274-1282.1996","article-title":"Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis","volume":"178","author":"Mahairas","year":"1996","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0235","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1126\/science.284.5419.1520","article-title":"Comparative genomics of BCG vaccines by whole-genome DNA microarray","volume":"284","author":"Behr","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0240","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1054\/tuld.1998.0201","article-title":"Survival of mice infected with Mycobacterium smegmatis containing large DNA fragments from Mycobacterium tuberculosis","volume":"79","author":"Bange","year":"1999","journal-title":"Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0245","doi-asserted-by":"crossref","first-page":"e1000507","DOI":"10.1371\/journal.ppat.1000507","article-title":"Systematic genetic nomenclature for type VII secretion systems","volume":"5","author":"Bitter","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0250","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MGM2-0025-2013","article-title":"Mycobacterial pathogenomics and evolution","volume":"2","author":"Bottai","year":"2014","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0255","doi-asserted-by":"crossref","first-page":"e1004650","DOI":"10.1371\/journal.ppat.1004650","article-title":"Cytosolic access of Mycobacterium tuberculosis: critical impact of phagosomal acidification control and demonstration of occurrence in vivo","volume":"11","author":"Simeone","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0260","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-2958.2002.03237.x","article-title":"Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti","volume":"46","author":"Pym","year":"2002","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0265","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1086\/421468","article-title":"Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens","volume":"190","author":"Brodin","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0270","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12251","article-title":"Release of mycobacterial antigens","volume":"264","author":"Majlessi","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0275","doi-asserted-by":"crossref","first-page":"33953","DOI":"10.1074\/jbc.M503515200","article-title":"Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity","volume":"280","author":"Brodin","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0280","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0285","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1164\/ajrccm.164.7.2101031","article-title":"Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island","volume":"164","author":"Caminero","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0290","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.4049\/jimmunol.174.6.3570","article-title":"Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system","volume":"174","author":"Majlessi","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0295","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.vaccine.2015.01.058","article-title":"Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis","volume":"33","author":"Sander","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0300","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1128\/IAI.72.4.2170-2176.2004","article-title":"Cell envelope protein PPE68 contributes to Mycobacterium tuberculosis RD1 immunogenicity independently of a 10-kilodalton culture filtrate protein and ESAT-6","volume":"72","author":"Demangel","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0305","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/infdis\/jiq089","article-title":"ESAT-6 secretion-independent impact of ESX-1 genes espF and espG1 on virulence of Mycobacterium tuberculosis","volume":"203","author":"Bottai","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0310","doi-asserted-by":"crossref","first-page":"S299","DOI":"10.1086\/313878","article-title":"Comparison of the protective efficacy of bacille calmette-Guerin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis","volume":"30","author":"Williams","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0315","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1128\/IAI.68.12.7094-7099.2000","article-title":"Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin","volume":"68","author":"Chambers","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0320","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tube.2004.11.001","article-title":"An assay to compare the infectivity of Mycobacterium tuberculosis isolates based on aerosol infection of guinea pigs and assessment of bacteriology","volume":"85","author":"Williams","year":"2005","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0325","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1073\/pnas.0700869104","article-title":"Genome plasticity of BCG and impact on vaccine efficacy","volume":"104","author":"Brosch","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0330","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tube.2004.09.009","article-title":"Evaluation of vaccines in the EU TB vaccine cluster using a guinea pig aerosol infection model of tuberculosis","volume":"85","author":"Williams","year":"2005","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0335","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0340","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-2249.2003.02171.x","article-title":"A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes","volume":"133","author":"Lopez","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0345","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1016\/j.vaccine.2013.07.051","article-title":"Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials","volume":"31","author":"Arbues","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0350","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1128\/IAI.56.12.3310-3312.1988","article-title":"Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines","volume":"56","author":"Orme","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0355","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1073\/pnas.90.11.5322","article-title":"Isolation of a proline-rich mycobacterial protein eliciting delayed-type hypersensitivity reactions only in guinea pigs immunised with living mycobacteria","volume":"90","author":"Romain","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0360","doi-asserted-by":"crossref","first-page":"e1002507","DOI":"10.1371\/journal.ppat.1002507","article-title":"Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death","volume":"8","author":"Simeone","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0365","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1462-5822.2012.01799.x","article-title":"ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria","volume":"14","author":"Houben","year":"2012","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0370","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1371\/journal.ppat.0040033","article-title":"Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP","volume":"4","author":"Frigui","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0375","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.chom.2008.01.002","article-title":"Mutation in the transcriptional regulator PhoP contributes to avirulence of Mycobacterium tuberculosis H37Ra strain","volume":"3","author":"Lee","year":"2008","journal-title":"Cell Host Microb"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0380","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/mmi.12720","article-title":"A glimpse into the past and predictions for the future: the molecular evolution of the tuberculosis agent","volume":"93","author":"Boritsch","year":"2014","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0385","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1473-3099(07)70108-1","article-title":"Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development","volume":"7","author":"Gagneux","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0390","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.smim.2014.09.009","article-title":"The formation of the granuloma in tuberculosis infection","volume":"26","author":"Orme","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0395","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1016\/j.vaccine.2006.03.017","article-title":"The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs","volume":"24","author":"Martin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0400","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nm.2420","article-title":"A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis","volume":"17","author":"Sweeney","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0405","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.chom.2012.03.003","article-title":"Strong immunogenicity and cross-reactivity of Mycobacterium tuberculosis ESX-5 Type VII secretion-encoded PE-PPE proteins predicts vaccine potential","volume":"11","author":"Sayes","year":"2012","journal-title":"Cell Host Microb"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0410","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/IAI.71.4.1672-1679.2003","article-title":"A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis","volume":"71","author":"Horwitz","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0415","doi-asserted-by":"crossref","first-page":"e01262","DOI":"10.1128\/mBio.01262-14","article-title":"Dietary pyridoxine controls efficacy of vitamin B6-auxotrophic tuberculosis vaccine bacillus Calmette-Guerin DeltaureC::hly Deltapdx1 in mice","volume":"5","author":"Gengenbacher","year":"2014","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2015.03.083_bib0420","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0966-842X(02)02345-4","article-title":"The ESAT-6\/WXG100 superfamily\u2014and a new gram-positive secretion system","volume":"10","author":"Pallen","year":"2002","journal-title":"Trends Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15004132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15004132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T16:04:07Z","timestamp":1598889847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15004132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":42,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0264410X15004132"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.083","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.03.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}